# Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy

> **NCT02247648** · PHASE2 · TERMINATED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 100 (actual)

## Conditions studied

- Pain
- Vertigo
- Nausea
- Pruritus

## Interventions

- **DRUG:** tramadol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02247648
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247648, "Efficacy of Extended-release, Once Daily Tramadol for Post Operative Analgesia in Shoulder Arthroscopy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02247648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*